A monthly injection could allow people with severe asthma to stop taking daily steroid tablets, a clinical trial has found.
More than 260 million people are thought to have asthma worldwide. While most can control their asthma with inhalers to…

A monthly injection could allow people with severe asthma to stop taking daily steroid tablets, a clinical trial has found.
More than 260 million people are thought to have asthma worldwide. While most can control their asthma with inhalers to…

Patients with

A new combined risk score that incorporates genetic factors may give clinicians a better idea of which patients with rheumatoid arthritis (RA) are most at risk for
The authors of the new report say they hope their…
A study led by Mass General Brigham researchers found that engasertib lessened bleeding events for patients with HHT, the second most common inherited bleeding disorder.
Hereditary hemorrhagic telangiectasia (HHT) is the second most common…

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) originally entered the market for the treatment of type 2 diabetes (T2D) in 2005 with the approval of exenatide (Byetta; Bristol Myers Squibb). In the past 20 years, GLP-1 RAs have gained…

Dengue, known for intense flu-like symptoms, crushing fatigue and body aches, reached record global levels in 2024 and researchers have attributed its spread to climate…

Officials are warning horse owners about an ongoing outbreak of equine herpesvirus after horses across multiple southern states have tested positive following two rodeo events earlier this month.
According to the Equine Disease Communication…

Officials are warning horse owners about an ongoing outbreak of equine herpesvirus after horses across multiple southern states have tested positive following two rodeo events earlier this month.
According to the Equine Disease Communication…